Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure
Abstract
Recent advances concerning effects of chronic nicotine exposure on nicotinic acetylcholine receptor (nAChR) expression are reviewed. Implications are assessed of these findings for roles of nAChR in health and disease and for design of drugs for treatment of neurological and psychiatric disorders. Most studies continue to show that chronic nicotine exposure induces increases in numbers of nAChR-like binding or antigenic sites ("upregulation") across all nAChR subtypes investigated, but with time- and dose-dependencies and magnitudes for these effects that are unique to subsets of nAChR subtypes. These effects appear to be post-transcriptionally based, but mechanisms involved remain obscure. With notable exceptions, most studies also show that chronic nicotine exposure induces several phases of nAChR functional loss ("desensitization" and longer-lasting "persistent inactivation") assessed in response to acute nicotinic agonist challenges. Times for onset and recovery and dose-dependencies for nicotine-induced functional loss also are nAChR subtype-specific. Some findings suggest that upregulation and functional loss are not causally- or mechanistically-related. It is suggested that upregulation is not as physiologically significant in vivo as functional effects of chronic nicotine exposure. By contrast, brain levels of nicotine in tobacco users, and perhaps levels of acetylcholine in the extracellular space, clearly are in the range that would alter the balance between nAChR in functionally ready or inactivated states. Further work is warranted to illuminate how effects of chronic nicotinic ligand exposure are integrated across nAChR subtypes and the neuronal circuits and chemical signaling pathways that they service to produce nicotine dependence and/or therapeutic benefit.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic administration of nicotinic agonists can desensitize rather than activate nAChRs, leading to functional antagonism.
“A number of studies have shown that chronic administration of nicotinic agonists (including nicotine through regular smoking or as delivered through the nicotine patch) can desensitize rather than activate nAChRs (Reitstetter et al., 1999), leading to functional antagonism (Gentry and Lukas, 2002; Quick and Lester, 2002).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Gentry and Lukas, 2002
nAChRs recover from desensitization on a timescale of seconds to hours.
“In fact, nAChRs recover from desensitization on the scale of seconds to hours (Gentry and Lukas 2002).”
From Nicotine Withdrawal (2015) · cites this paper as Gentry and Lukas 2002
nAChR upregulation varies by receptor subtype, brain region, and contingency of nicotine administration.
“Relevant to the understanding of the neuroadaptations produced by nicotine is the fact that nAChR upregulation differs among receptor subtypes, varies among brain regions for the same subtype, and even depends on the contingency of nicotine administration [9, 90, 93].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [93]
Chronic nicotine treatment causes upregulation of β2* nAChRs and also desensitization of nAChRs.
“Chronic nicotine treatment results in an upregulation of β2* nAChRs (Marks et al., 1983; Schwartz and Kellar, 1983) but also a desensitization of nAChRs (Gentry and Lukas, 2002).”
From The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation (2012) · cites this paper as Gentry and Lukas, 2002
In vitro studies have shown that nAChRs return from a desensitized state within minutes to hours.
“in vitro studies have shown that nAChRs return from a desensitized state in minutes to hours (see Gentry and Lukas (2002) for review).”
From The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation (2012) · cites this paper as Gentry and Lukas (2002)
Upregulation of high-sensitivity nAChRs is, at least partially, the basis for tolerance, locomotor sensitization, and cognitive sensitization caused by chronic nicotine administration.
“But increasing evidence suggests that upregulation of high-sensitivity nAChRs is, at least partially, the basis for several key biological results of chronic nicotine administration: tolerance, locomotor sensitization, and cognitive sensitization (5,10–12).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [11]
Cites
Still being checked.
Cited by
Sorted by citations
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works
The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour
Laviolette, S. R., & van der Kooy, D. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1298 · Cited by 452 · see citing works
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400 · see citing works
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 307 · see citing works
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275 · see citing works
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · see citing works
Nicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works
Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine
Kenney, J. W., & Gould, T. J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8037-9 · Cited by 242 · see citing works
Young, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 219 · see citing works
Smoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 201 · see citing works
Moylan, S., Jacka, F. N., Pasco, J. A., & Berk, M. (2013) · Brain and Behavior · doi:10.1002/brb3.137 · Cited by 186 · see citing works
Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 185 · see citing works
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works
Dual role of nicotine in addiction and cognition: A review of neuroimaging studies in humans
Jasinska, A. J., Zorick, T. S., Brody, A. L., & Stein, E. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.015 · Cited by 163 · see citing works
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works
Nicotine and serotonin in immune regulation and inflammatory processes: a perspective
Cloëz-Tayarani, I., & Changeux, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906544 · Cited by 145 · see citing works
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137 · see citing works
Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates
Quik, M., Parameswaran, N., McCallum, S. E., Bordia, T., Bao, S., McCormack, A. L., Kim, A., Tyndale, R. F., Langston, J. W., & Monte, D. A. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04078.x · Cited by 137 · see citing works
Naturally-expressed nicotinic acetylcholine receptor subtypes
Wu, J., & Lukas, R. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.067 · Cited by 136 · see citing works
Self-citationRichards, J. M., Stipelman, B. A., Bornovalova, M. A., Daughters, S. B., Sinha, R., & Lejuez, C. W. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.06.009 · Cited by 132 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 129 · see citing works
Desensitized nicotinic receptors in brain
Wang, H., & Sun, X. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.003 · Cited by 175 · see citing works
Nicotine: specific role in angiogenesis, proliferation and apoptosis
Cardinale, A., Nastrucci, C., Cesario, A., & Russo, P. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.623150 · Cited by 123 · see citing works
Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 115 · see citing works
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity
Rezvani, K., Teng, Y., Shim, D., & De Biasi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-07.2007 · Cited by 113 · see citing works
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 108 · see citing works
Timing of nicotine effects on learning in zebrafish
Levin, E. D., Limpuangthip, J., Rachakonda, T. D., & Peterson, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0162-9 · Cited by 104 · see citing works
Lee, A. M., & Messing, R. O. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.022 · Cited by 101 · see citing works
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100 · see citing works
Wing, V. C., Wass, C., Soh, D. W., & George, T. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06261.x · Cited by 99 · see citing works
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works
Duncan, J. R., Garland, M., Myers, M. M., Fifer, W. P., Yang, M., Kinney, H. C., & Stark, R. I. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91629.2008 · Cited by 93 · see citing works
Melis, M., Scheggi, S., Carta, G., Madeddu, C., Lecca, S., Luchicchi, A., Cadeddu, F., Frau, R., Fattore, L., Fadda, P., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4647-12.2013 · Cited by 94 · see citing works
Nicotinic acetylcholine receptors of adrenal chromaffin cells
Sala, F., Nistri, A., & Criado, M. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01804.x · Cited by 90 · see citing works
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89 · see citing works
Liang, K., Poytress, B. S., Chen, Y., Leslie, F. M., Weinberger, N. M., & Metherate, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04945.x · Cited by 89 · see citing works
Xu, J.-S., Fregni, F., Brody, A., & Rahman, A. S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00112 · Cited by 84 · see citing works
Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?
Balakumar, P., & Kaur, J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.005 · Cited by 82 · see citing works
Marks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 81 · see citing works
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms
Dutertre, S., Nicke, A., & Tsetlin, V. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.011 · Cited by 77 · see citing works
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 79 · see citing works
Quik, M., Chen, L., Parameswaran, N., Xie, X., Langston, J. W., & McCallum, S. E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0215-06.2006 · Cited by 77 · see citing works
NEW INSIGHTS INTO THE SYMPATHETIC, ENDOTHELIAL AND CORONARY EFFECTS OF NICOTINE
Adamopoulos, D. N., van de Borne, P., & Argacha, J. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04896.x · Cited by 76 · see citing works
Chen, H., Parker, S. L., Matta, S. G., & Sharp, B. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04229.x · Cited by 73 · see citing works
Non-Nicotinic Therapies for Smoking Cessation
Siu, E. C. K., & Tyndale, R. F. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105354 · Cited by 69 · see citing works
The Pharmacological Actions of Nicotine on the Gastrointestinal Tract
Wu, W. K. K., & Cho, C. H. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.348 · Cited by 70 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Neurocognitive endophenotypes in schizophrenia: Modulation by nicotinic receptor systems
Mackowick, K. M., Barr, M. S., Wing, V. C., Rabin, R. A., Ouellet‐Plamondon, C., & George, T. P. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.010 · Cited by 65 · see citing works
Tobacco smoking, harm reduction, and nicotine product regulation
Britton, J. R., & Edwards, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61482-2 · Cited by 65 · see citing works
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64 · see citing works
Mugnaini, M., Garzotti, M., Sartori, I., Pilla, M. A., Repeto, P., Heidbreder, C. A., & Tessari, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.008 · Cited by 64 · see citing works
Haig, G. M., Bain, E., Robieson, W., Baker, J. D., & Othman, A. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010093 · Cited by 61 · see citing works
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
Gandelman, J. A., NEWHOUSE, P. A., & Taylor, W. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.018 · Cited by 61 · see citing works
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits
Davis, J. A., & Gould, T. J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.003 · Cited by 60 · see citing works
Behavioral and Molecular Analysis of Nicotine-Conditioned Place Preference in Zebrafish
Kedikian, X., Faillace, M. P., & Bernabeu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069453 · Cited by 59 · see citing works
Moretti, M., Mugnaini, M., Tessari, M., Zoli, M., Gaimarri, A., Manfredi, I., Pistillo, F., Clementi, F., & Gotti, C. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064071 · Cited by 58 · see citing works
Laviolette, S. R., Lauzon, N. M., Bishop, S. F., Sun, N., & Tan, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1371-08.2008 · Cited by 58 · see citing works
Gould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56 · see citing works
Alkam, T., Kim, H., Hiramatsu, M., Mamiya, T., Aoyama, Y., Nitta, A., Yamada, K., & Nabeshima, T. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.058 · Cited by 56 · see citing works
Weiss, S., Nosten‐Bertrand, M., McIntosh, J. M., Bruno Giros, A., & Martres, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301385 · Cited by 54 · see citing works
Pathogenesis of Abdominal Aortic Aneurysms: Role of Nicotine and Nicotinic Acetylcholine Receptors
Li, Z., & Dai, Q. (2012) · Mediators of Inflammation · doi:10.1155/2012/103120 · Cited by 55 · see citing works
Chronic exposure to nicotine impairs cholinergic angiogenesis
Konishi, H., Wu, J., & Cooke, J. P. (2009) · Vascular Medicine · doi:10.1177/1358863x09106326 · Cited by 55 · see citing works
Alkam, T., Kim, H.-C., Mamiya, T., Yamada, K., Hiramatsu, M., & Nabeshima, T. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3175-9 · Cited by 50 · see citing works
Khwaja, M., McCormack, A., McIntosh, J. M., Di Monte, D. A., & Quik, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04177.x · Cited by 54 · see citing works
Potential therapeutic uses of mecamylamine and its stereoisomers
Nickell, J. R., Grinevich, V. P., Siripurapu, K. B., Smith, A. M., & Dwoskin, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.005 · Cited by 52 · see citing works
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51 · see citing works
del Barrio, L., Martin‐de‐Saavedra, M. D., Romero, A., Parada, E., Egea, J., Ávila, J., McIntosh, J. M., Wonnacott, S., & López, M. G. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr163 · Cited by 51 · see citing works
Fregosi, R. F., & Pilarski, J. Q. (2008) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.05.008 · Cited by 48 · see citing works
Alkondon, M., & Albuquerque, E. X. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081232 · Cited by 50 · see citing works
Associative Learning, the Hippocampus, and Nicotine Addiction
Gould, T. J., & Davis, J. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010009 · Cited by 49 · see citing works
Cholinergic Modulation of Appetite-Related Synapses in Mouse Lateral Hypothalamic Slice
Jo, Y., Wiedl, D., & Role, L. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3638-05.2005 · Cited by 48 · see citing works
Cellular trafficking of nicotinic acetylcholine receptors
John, P. A. S. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.76 · Cited by 47 · see citing works
Gentry, C. L., Wilkins, L. H., & Lukas, R. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041756 · Cited by 47 · see citing works
Self-citationChristensen, D. Z., Mikkelsen, J. D., Hansen, H. H., & Thomsen, M. S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06845.x · Cited by 46 · see citing works
Thomsen, M. S., Weyn, A., & Mikkelsen, J. D. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00961.x · Cited by 46 · see citing works
Profita, M., Bonanno, A., Montalbano, A. M., Ferraro, M., Siena, L., Bruno, A., Girbino, S., Albano, G. D., Casarosa, P., Pieper, M. P., et al. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.04.025 · Cited by 46 · see citing works
ACUTE EFFECTS OF NICOTINE ON ARTERIAL STIFFNESS AND WAVE REFLECTION IN HEALTHY YOUNG NON‐SMOKERS
Adamopoulos, D. N., Argacha, J., Gujic, M., Preumont, N., Degaute, J.-P., & van de Borne, P. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05141.x · Cited by 45 · see citing works
The Role of CaMKII and ERK Signaling in Addiction
Jia, W., Kawahata, K., Cheng, A., & Fukunaga, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063189 · Cited by 45 · see citing works
Huang, Y.-H., Brown, A. R., Cross, S. J. B., Cruz, J. C., Rice, A. D., Jaiswal, S. J., & Fregosi, R. F. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01036.2009 · Cited by 44 · see citing works
The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development
Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/104105 · Cited by 43 · see citing works
Paulo, J. A., & Gygi, S. P. (2016) · PROTEOMICS · doi:10.1002/pmic.201600319 · Cited by 41 · see citing works
Vihavainen, T., Piltonen, M., Tuominen, R. K., Korpi, E. R., & Ahtee, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.028 · Cited by 43 · see citing works
Developmental Nicotine Exposure Alters Neurotransmission and Excitability in Hypoglossal Motoneurons
Pilarski, J. Q., Wakefield, H. E., Fuglevand, A. J., Levine, R. B., & Fregosi, R. F. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00876.2010 · Cited by 40 · see citing works
Avila, A. M., Dávila‐García, M. I., Ascarrunz, V. S., Xiao, Y., & Kellar, K. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.974 · Cited by 40 · see citing works
Nicotine and ethanol interact during adolescence: Effects on the central cholinergic systems
Ribeiro‐Carvalho, A., Lima, C. S., Filgueiras, C. C., Manhães, A. C., & Abreu‐Villaça, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.062 · Cited by 39 · see citing works
Rowe, A. R., Mercer, L., Casetti, V., Sendt, K.-V., Giaroli, G., Shergill, S. S., & Tracy, D. K. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114564096 · Cited by 38 · see citing works
Kayır, H., Semenova, S., & Markou, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.007 · Cited by 37 · see citing works
Knott, V., Millar, A., McIntosh, J. F., Shah, D. K., Fisher, D. J., Blais, C. M., Ilivitsky, V., & Horn, E. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.06.012 · Cited by 37 · see citing works
The insula in nicotine use disorder: Functional neuroimaging and implications for neuromodulation
Regner, M. F., Tregellas, J. R., Kluger, B. M., Wylie, K. P., Gowin, J. L., & Tanabe, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.002 · Cited by 34 · see citing works
Olson, L. C., Hong, D., Conell‐Price, J., Cheng, S., & Flood, P. D. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181bd1612 · Cited by 34 · see citing works
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 32 · see citing works
Nuutinen, S., Ahtee, L., & Tuominen, R. K. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.003 · Cited by 33 · see citing works
Nicotinic Receptors and Attention
Hahn, B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_5 · Cited by 32 · see citing works
Jaiswal, S. J., Pilarski, J. Q., Harrison, C. M., & Fregosi, R. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-12.2013 · Cited by 32 · see citing works
- Authors
- Gentry, C., & Lukas, R.
- Affiliations
- Barrow Neurological Institute (US)
- Venue
- Current Drug Target -CNS & Neurological Disorders
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2002-08-01
- Volume
- 1
- Issue
- 4
- Pages
- 359-385
- ISSN
- 1568-007X (ISSN-L)
- OpenAlex
- W2024690874
- Cited by
- 232
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 25 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 14 · 2015: 5 · 2014: 8 · 2013: 12 · 2012: 7
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic acetylcholine receptors, chronic nicotine exposure, receptor up-regulation, receptor desensitization, nAChR subtypes, post-transcriptional regulation, nicotine dependence, acetylcholine, tobacco use, nicotinic agonists
- MeSH terms
- Animals, Humans, Ligands, Nicotine, Receptors, Nicotinic, Tobacco Use Disorder, Up-Regulation, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review